Search

Search Constraints

You searched for: Author/Creator Matthews, Dawn C.

Search Results

2. [P4–014]: THE COALITION AGAINST MAJOR DISEASES: TOWARD U.S. FDA QUALIFICATION OF HIPPOCAMPAL VOLUME AS A BIOMARKER FOR ENRICHMENT IN CLINICAL TRIALS FOR PRE‐DEMENTIA STAGES OF ALZHEIMER'S DISEASE. (1st July 2017)

3. Development, initial validation, and application of a visual read method for [18F]MK‐6240 tau PET. Issue 1 (12th February 2023)

4. Dissociation of Down syndrome and Alzheimer's disease effects with imaging. Issue 2 (8th March 2016)

5. Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes. Issue 1 (14th March 2022)

7. Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults. (15th May 2018)

10. P1‐380: MRI CLASSIFIERS CHARACTERIZE MILD TRAUMATIC BRAIN INJURY IN SYMPTOMATIC AND PRESYMPTOMATIC STAGES AND DIFFERENTIATE FROM ALZHEIMER'S DISEASE–RELATED IMPAIRMENT. (1st July 2006)